Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
Patients with severe sickle cell disease were more than twice as likely to experience recurrent thromboembolism compared with patients with less severe disease.
Venous thromboembolism risk similar for patients with gout regardless of urate-lowering therapy.
In this 3-part series, Hematology Advisor spoke with experts about the revisions to the ASH clinical practice guidelines for venous thromboembolism.
The guidelines were developed by over 100 experts, including hematologists, patient representatives, and other specialists.
Among patients undergoing total knee arthroplasty, aspirin alone may provide protection against postoperative venous thromboembolism that is similar to that of other anticoagulants.
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years.
Mendelian randomization analysis provides evidence that increased height causally tied to varicose veins.
Incidence of major bleeding low with rivaroxaban, but clot risk not lower.
Migraines are linked to cardiovascular events, including myocardial infarction, VTE, and stroke.
